{"SPADE_N_14552": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_14552", "Peptide Name": "RI-18 (AN-1, RA-48 fragment, Lys-rich, synthetic AMPs, UCLL1)", "Source": "sequence truncation, reptiles, animal-derived, natural derivatives", "Family": "Not found", "Gene": "Not found", "Sequence": "RRGIKKFIKKVKKVKKAI", "Sequence Length": 18, "UniProt Entry": "Ref", "Protein Existence": "Not found", "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anti-MRSA"], "Target Organism": "Not found", "Hemolytic Activity": "Not found", "Cytotoxicity": "Not found", "Binding Target": "Not found", "Linear/Cyclic": "Not found", "N-terminal Modification": "Not found", "C-terminal Modification": "Not found", "Stereochemistry": "Not found", "Structure Description": "Not found", "Formula": "Not found", "Mass": 2168.8, "PI": 12.0, "Hydrophobicity": -0.78, "Half Life": "Not found", "Function": "Not found", "Literature": [{"Author": "Wu Z, Cai Y, Han Y, Su Y, Zhang T, Wang X, Yan A, Wang L, Wu S, Wang G, Zhang Z. 2024", "Reference": "J Med Chem. 2024 Nov 1. doi: 10.1021/acs.jmedchem.4c01855.PubMed", "Title": "Development of alpha-Helical Antimicrobial Peptides with Imperfect Amphipathicity for Superior Activity and Selectivity."}], "Frequent Amino Acids": "KIR", "Absent Amino Acids": "CDEHLMNOPQSTUWY", "Basic Residues": 10, "Acidic Residues": 0, "Hydrophobic Residues": 7, "Polar Residues": 13, "Positive Residues": 10, "Negative Residues": 0, "Net Charge": 10, "Comments": "Sequence analysis: APD analysis reveals that this sequence is similar (60%) toRL-30K: 44%, I: 17%, V=R: 11%.Activity: active against S. aureus ATCC6538 and 7 clinical strains and 9 MRSA strains (MIC 2.34 ug/ml), A. baumannii ATCC19606 and 3 clinical strains (MIC 2.34-4.68 ug/ml), three E. coli clinical strains (MIC 9.37-18.75 ug/ml), P. aeruginosa 4 clinical strains (MIC 1.17-4.68 ug/ml).Inhibited bioffilm formation:bacteria:P. aeruginosa and disrupted biofilms by 60%; Inhibited biofilm formation:bacteria:A. baumannii and disrupted biofilms by 30% at 5x or 10x MIC; Inhibited biofilm formation:bacteria:S. aureus and disrupted biofilms by 60%. Kill persisters as well.In vitro toxicity: not hemo.lytic till 100 ug/ml.  Not toxic to HEK293 and HaCaT cells.Structure:  random coil in water and helical in SDS.In vivo toxicity: IV injection 10-20 mg/kg peptide showed no sign of toxicity in 48 h.", "Similar Sequences": [{"SPADE_ID": "SPADE_N_13972", "Similarity": 1.0, "Sequence": "RRGIKKFIKKVKKVKKAIKEGIKKGIKKLLSGGGSNIAHGPGGRRHIA"}, {"SPADE_ID": "SPADE_N_14551", "Similarity": 1.0, "Sequence": "RRGIKKFIKKVKKVKKAIKEGIKKGIKKLL"}, {"SPADE_ID": "SPADE_UN_26657", "Similarity": 1.0, "Sequence": "RRGIKKFIKKVKKVKKAIKEGIKKGIKKLL"}]}}}